SAN DIEGO

,

Nov. 19, 2021

/PRNewswire/ — Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that Chief Executive Officer

Saundra Pelletier

will participate in a fireside chat and host one-on-one meetings at the Piper Sandler 33

^rd

Annual Virtual Healthcare Conference being held from

November 29

–

December 2, 2021

.

The Company’s pre-recorded fireside chat will be available for on demand listening beginning at

10:00am ET

(

7:00am PT

) on

Monday, November 22, 2021

for 90 days through the Piper Sandler conference site and at

https://evofem.investorroom.com/Piper2021

.

To request a one-on-one meeting with Evofem during the conference, please contact your Piper Sandler representative.

About Evofem Biosciences


Evofem Biosciences, Inc., (NASDAQ: EVFM) is developing and commercializing innovative products to address unmet needs in women’s sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (chlamydia and gonorrhea). The Company’s first FDA-approved product, Phexxi® (lactic acid, citric acid and potassium bitartrate), is a hormone-free, on-demand prescription contraceptive vaginal gel. It comes in a box of 12 pre-filled applicators and is applied 0-60 minutes before each act of sex. Learn more at phexxi.com and

evofem.com

.

Phexxi

^®

is a registered trademark of Evofem Biosciences, Inc.

Investor Relations Contact



Amy Raskopf


Evofem Biosciences, Inc.



[email protected]



Mobile: (917) 673-5775

View original content to download multimedia:

https://www.prnewswire.com/news-releases/evofem-biosciences-to-participate-in-piper-sandler-33rd-annual-healthcare-conference-301428861.html

SOURCE Evofem Biosciences, Inc.